Evidence map›Paper›PMID 36380961›Full record

ArticleRSC advances2022

Bioevaluation of magnetic mesoporous silica rods: cytotoxicity, cell uptake and biodistribution in zebrafish and rodents.

Jan Grzelak, Mariana Teles, Nerea Roher, Alba Grayston, Anna Rosell, Martí Gich, Anna Roig

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. ComparativeDalton transactions (Cambridge, England : 2003) · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jan GrzelakInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC) Campus UAB, 08193 Bellaterra Catalonia Spain mgich@icmab.es anna.roig@csic.es.ORCID https://orcid.org/0000-0002-8404-0389
Mariana TelesInstitute of Biotechnology and Biomedicine (IBB), Universitat Autònoma de Barcelona 08193 Barcelona Spain.
Nerea RoherInstitute of Biotechnology and Biomedicine (IBB), Universitat Autònoma de Barcelona 08193 Barcelona Spain.ORCID https://orcid.org/0000-0002-6659-4038
Alba GraystonNeurovascular Research Laboratory, Vall d'Hebron Research Institute (VHIR) 08035 Barcelona Catalonia Spain.
Anna RosellNeurovascular Research Laboratory, Vall d'Hebron Research Institute (VHIR) 08035 Barcelona Catalonia Spain.
Martí GichInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC) Campus UAB, 08193 Bellaterra Catalonia Spain mgich@icmab.es anna.roig@csic.es.
Anna RoigInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC) Campus UAB, 08193 Bellaterra Catalonia Spain mgich@icmab.es anna.roig@csic.es.ORCID https://orcid.org/0000-0001-6464-7573
Institut de Ciència de Materials de Barcelona · ESUniversitat Autònoma de Barcelona · ESVall d'Hebron Institut de Recerca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesoporous silica nanoparticles (MSN) characterized by large surface area, pore volume, tunable chemistry, and biocompatibility have been widely studied in nanomedicine as imaging and therapeutic carriers. Most of these studies focused on spherical particles. In contrast, mesoporous silica rods (MSR) that are more challenging to prepare have been less investigated in terms of toxicity, cellular uptake, or biodistribution. Interestingly, previous studies showed that silica rods penetrate fibrous tissues or mucus layers more efficiently than their spherical counterparts. Recently, we reported the synthesis of MSR with distinct aspect ratios and validated their use in multiple imaging modalities by loading the pores with maghemite nanocrystals and functionalizing the silica surface with green and red fluorophores. Herein, based on an initial hypothesis of high liver accumulation of the MSR and a future vision that they could be used for early diagnosis or therapy in fibrotic liver diseases; the cytotoxicity and cellular uptake of MSR were assessed in zebrafish liver (ZFL) cells and the

Identifiers

PMID36380961
PMCPMC9639086
OpenAlexW4309244375

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.